Showing 31-40 of 156 results for "".
Journal Club: Updates in Topical Treatments for AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-updates-topical-treatments-ad/29744/Editorial Board member and dermatologist Dr. Peter Lio talks with Dr. Ted Lain, a dermatologist at Sanova Dermatology, about the latest research and developments in topical treatments for AD. The discussion covers a range of therapies highlighted in an article from the Dermatologic Clinics article "DermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecBetter Brow Lifts
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/better-brow-lifts/18302/An effective neuromodulator brow lift depends on identifying two key points that will help determine the ideal injection location, says Joel L. Cohen, MD, a dermatologist in Greenwood Village, CO. The key is to inject the orbicularis oculi only and to avoid the frontalis entirely. Dr. Cohen is co-ed- Adriane M. Brown Joins Allergan's Board of Directorshttps://practicaldermatology.com/news/adriane-m-brown-joins-allergans-board-of-directors/2458375/Adriane M. Brown is joining Allergan’s board of directors effective February 2017. Ms. Brown is currently President and Chief Operating Officer of Intellectual Ventures LLC, a private global invention company focused on providing access to valua
- TOOsonix A/S Rolls Out System ONE-M for Aesthetic Treatmentshttps://practicaldermatology.com/news/toosonix-as-rolls-out-system-one-m-for-aesthetic-treatments/2460449/TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultrasound device operati
- Dr. Richard M. Goldfarb Named Medical Director of DBM Corporationhttps://practicaldermatology.com/news/dr-richard-m-goldfarb-named-medical-director-ofdbm-corporation/2460145/Richard M. Goldfarb MD, is the new Medical Director of DBM Corporation Inc. is the official US representative of MIRACU PDO Threads. In this role, Dr. Goldfarb, the founder of the Center for SmartLipo & Plastic Surgery in the Philadelphia
- Lisa M. Donofrio, MD Takes Reins of ASDS/ASDSAhttps://practicaldermatology.com/news/lisa-m-donofrio-md-takes-reins-of-asdsasdsa/2458023/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA
- Third Harmonic Bio Appoints Thomas M. Soloway to its Board of Directorshttps://practicaldermatology.com/news/third-harmonic-bio-appoints-thomas-m-soloway-to-its-board-of-directors/2461292/Thomas M. Soloway is now a member of Third Harmonic Bio, Inc.’s Board of Directors. Mr. Soloway brings more than 25 years of experience in the life sciences industry, with senior roles in strategy, operations, corporate finance and venture capital to the company,
- Message from ASLMS President Dr. Paul M. Friedmanhttps://practicaldermatology.com/news/message-from-aslms-president-dr-paul-m-friedman/2461221/Dr. Paul M. Friedman, president of the American Society for Laser Medicine and Surgery (ASLMS), is calling on members to expand philanthropic programs that can help change lives with lasers. “In the coming year, I will be looking to the membership to bring their talents forwa
- TOOsonix System ONE-M BCC Clinical Trial Updatehttps://practicaldermatology.com/news/toosonix-system-one-m-bcc-clinical-trial-update/2461162/The first basal cell carcinoma (BCC) patients have been treated with TOOsonix A/S’s System ONE-M device. The TOOsonix high-intensity focused ultrasound (HIFU) delivers highly accurate doses of energy to focal points in a chosen depth. It operates at 20 MHz to